UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 255

Sortiert nach

Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)

ESMO open, 2024-05, Vol.9 (5), p.103009, Article 103009

2024

Volltextzugriff (PDF)

Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases

Clinical cancer research, 2023-10, Vol.29 (20), p.4230

2023

Volltextzugriff (PDF)

Abstract GS5-02: Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency – long-term survival of the GeparOLA study

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.GS5-02-GS5-02

2023

Volltextzugriff (PDF)

Abstract P4-06-13: Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency – long-term survival of the GeparOLA study

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-06-13

2023

Volltextzugriff (PDF)

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer cell, 2022-08, Vol.40 (8), p.850-864.e9

2022

Volltextzugriff (PDF)

Activation mechanisms in the catalyst coated membrane of PEM fuel cells

Progress in energy and combustion science, 2021-07, Vol.85, p.100924, Article 100924

2021

Volltextzugriff (PDF)

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

Annals of oncology, 2021-01, Vol.32 (1), p.49-57

2021

Volltextzugriff (PDF)

160O Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer, TNBC) (PM(Cb)) for patients (pts) with high-risk early breast cancer (BC)

Annals of oncology, 2020-09, Vol.31, p.S303-S304

2020

Volltextzugriff (PDF)

Management of the axilla for high-risk early breast cancer (EBC) before and after neoadjuvant chemotherapy (NACT): an analysis of the multicentre GeparOcto trial

Geburtshilfe und Frauenheilkunde, 2020, Vol.80 (6)

2020

Volltextzugriff (PDF)

A Nosocomial Cluster of Tigecycline- and Vancomycin-Resistant Enterococcus faecium Isolates and the Impact of rpsJ and tet (M) Mutations on Tigecycline Resistance

Microbial drug resistance (Larchmont, N.Y.), 2020-06, Vol.26 (6), p.576

2020

Volltextzugriff (PDF)

Validating a screening agar for linezolid-resistant enterococci

BMC infectious diseases, 2019-12, Vol.19 (1), p.1078-5, Article 1078

2019

Volltextzugriff (PDF)

Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort

Blood, 2019-11, Vol.134 (Supplement_1), p.1407-1407

2019

Volltextzugriff (PDF)

Comparison of VITEK® 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs

Journal of antimicrobial chemotherapy, 2019-10, Vol.74 (10), p.2926-2929

2019

Volltextzugriff (PDF)

Development of a multiplex-PCR to simultaneously detect acquired linezolid resistance genes cfr, optrA and poxtA in enterococci of clinical origin

Journal of microbiological methods, 2019-05, Vol.160, p.101-103

2019

Volltextzugriff (PDF)

West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer

Journal of clinical oncology, 2019-04, Vol.37 (10), p.799-808

2019

Volltextzugriff (PDF)

A Core Genome Multilocus Sequence Typing Scheme for Enterococcus faecalis

Journal of clinical microbiology, 2019-03, Vol.57 (3)

2019

Volltextzugriff (PDF)

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto

Annals of oncology, 2018-12, Vol.29 (12), p.2341-2347

2018

Volltextzugriff (PDF)

Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates

International journal of antimicrobial agents, 2018-12, Vol.52 (6), p.819-827

2018

Volltextzugriff (PDF)

Bergung eines migrierten Doppel-Pigtail-Stents bei einem 51-jährigen Patienten

Der Internist (Berlin), 2018-10, Vol.59 (10), p.1100-1105

2018

Volltextzugriff (PDF)

Retrieval of a migrated plastic stent in a 51-year-old man

Der Internist (Berlin), 2018-10, Vol.59 (10), p.1100-1105

2018

Volltextzugriff (PDF)

Use of Bioorthogonal N‐Acetylcysteamine (SNAc) Analogues and Peptidoglycan O‐Acetyltransferase B (PatB) to Label Peptidoglycan

The FASEB journal, 2018-04, Vol.32 (S1), p.673.30-673.30

2018

Volltextzugriff (PDF)

Abstract GS3-03: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS3-03-GS3-03

2018

Volltextzugriff (PDF)

In-line XPS to quantify the changes in interfacial layers of advanced node gate stacks

2018 29th Annual SEMI Advanced Semiconductor Manufacturing Conference (ASMC), 2018, p.84-88

2018

Volltextzugriff (PDF)

Postsynthetic Modification of Bacterial Peptidoglycan Using Bioorthogonal N‑Acetylcysteamine Analogs and Peptidoglycan O‑Acetyltransferase B

Journal of the American Chemical Society, 2017-10, Vol.139 (39), p.13596-13599

2017

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(216)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(230)
Deutsch
(26)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)

Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases

Abstract GS5-02: Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency – long-term survival of the GeparOLA study

Abstract P4-06-13: Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency – long-term survival of the GeparOLA study

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Activation mechanisms in the catalyst coated membrane of PEM fuel cells

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

160O Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer, TNBC) (PM(Cb)) for patients (pts) with high-risk early breast cancer (BC)

Management of the axilla for high-risk early breast cancer (EBC) before and after neoadjuvant chemotherapy (NACT): an analysis of the multicentre GeparOcto trial

A Nosocomial Cluster of Tigecycline- and Vancomycin-Resistant Enterococcus faecium Isolates and the Impact of rpsJ and tet (M) Mutations on Tigecycline Resistance

Validating a screening agar for linezolid-resistant enterococci

Framework to Identify and Prioritize Candidate Inherited Myeloid Malignancy Germline Variants Leveraging the BEAT AML Cohort

Comparison of VITEK® 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs

Development of a multiplex-PCR to simultaneously detect acquired linezolid resistance genes cfr, optrA and poxtA in enterococci of clinical origin

West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer

A Core Genome Multilocus Sequence Typing Scheme for Enterococcus faecalis

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto

Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates

Bergung eines migrierten Doppel-Pigtail-Stents bei einem 51-jährigen Patienten

Retrieval of a migrated plastic stent in a 51-year-old man

Use of Bioorthogonal N‐Acetylcysteamine (SNAc) Analogues and Peptidoglycan O‐Acetyltransferase B (PatB) to Label Peptidoglycan

Abstract GS3-03: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial)

In-line XPS to quantify the changes in interfacial layers of advanced node gate stacks

Postsynthetic Modification of Bacterial Peptidoglycan Using Bioorthogonal N‑Acetylcysteamine Analogs and Peptidoglycan O‑Acetyltransferase B

Suchergebnisse filtern